Search
Close this search box.

ACtero

Academy

گفتمان

با یک متخصص مراقبت های بهداشتی

چگونه صحبت می کنیم

رسمی

صریح

فنی

دقیق

The Lancet Oncology

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (Gepa1)

Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Costa, Hans Tesch, Claus Hanusch, Jörn Hilfrich, Fariba Khandan, Peter A Fasching, Bruno V Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch

بارگذاری | Download

Critical Reviews in Oncology / Hematology

Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis

Rui Pedro Marquesa,b,⁎, Gonçalo S. Duartec,d,e, Carmelo Sterrantinof,g, Helena Luna Paisb, António Quintelab, Ana Paula Martinsa, João Costac,d,e

بارگذاری | Download

the Oncologist

FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis

FILIPPO PIETRANTONIO,a,b,† GIOVANNI FUCÀ ,a,† DANIELE ROSSINI,c,d HANS-JOACHIM SCHMOLL,e JOHANNA C. BENDELL,f FEDERICA MORANO,a CARLOTTA ANTONIOTTI,c,d SALVATORE CORALLO,a BEATRICE BORELLI,c,d ALESSANDRA RAIMONDI,a FEDERICA MARMORINO,c,d MONICA NIGER,a ALESSANDRA BOCCACCINO,c,d GIANLUCA MASI,c,d SARA LONARDI,g LUCA BONI,h FILIPPO DE BRAUD,a,b MARIA DI BARTOLOMEO,a ALFREDO FALCONE,c,d CHIARA CREMOLINIc,d

بارگذاری | Download

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Costa, Hans Tesch, Claus Hanusch, Jörn Hilfrich, Fariba Khandan, Peter A Fasching, Bruno V Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch

بارگذاری | Download

The new england journal of medicine

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

N.D. James, J.S. de Bono, M.R. Spears, N.W. Clarke, M.D. Mason, D.P. Dearnaley, A.W.S. Ritchie, C.L. Amos, C. Gilson, R.J. Jones, D. Matheson, R. Millman, G. Attard, S. Chowdhury, W.R. Cross, S. Gillessen, C.C. Parker, J.M. Russell, D.R. Berthold, C. Brawley, F. Adab, S. Aung, A.J. Birtle, J. Bowen, S. Brock, P. Chakraborti, C. Ferguson, J. Gale, E. Gray, M. Hingorani, P.J. Hoskin, J.F. Lester, Z.I. Malik, F. McKinna, N. McPhail, J. Money‑Kyrle, J. O’Sullivan, O. Parikh, A. Protheroe, A. Robinson, N.N. Srihari, C. Thomas, J. Wagstaff, J. Wylie, A. Zarkar, M.K.B. Parmar, and M.R. Sydes, for the STAMPEDE Investigators

بارگذاری | Download

British Journal Of Center

FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

Volker Heinemann1, Ludwig Fischer von Weikersthal2, Thomas Decker3, Alexander Kiani4, Florian Kaiser5, Salah-Edin Al-Batran6, Tobias Heintges7, Christoph Lerchenmüller8, Christoph Kahl9, Gernot Seipelt10, Frank Kullmann11, Markus Moehler12, Werner Scheithauer13, Swantje Held14, Lisa Miller-Phillips1, Dominik Paul Modest1, Andreas Jung15, Thomas Kirchner15 and Sebastian Stintzing16

بارگذاری | Download

Journal of B.U.ON.

Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer?

Yakup Ergun, Oznur Bal, Mutlu Dogan, Dogan Uncu Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey

بارگذاری | Download

Nature

Bevacizumab plus capecitabine as later‑line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

Yeong Hak Bang1,3,4, Jeong Eun Kim1,4, Ji Sung Lee2, SunYoung Kim1, Kyu‑Pyo Kim1, Tae Won Kim1 & Yong Sang Hong

بارگذاری | Download

JOURNAL OF CLINICAL ONCOLOGY

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais

بارگذاری | Download

JOURNAL OF CLINICAL ONCOLOGY

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Katherine S. Virgo, PhD, MBA1; R. Bryan Rumble, MSc2; Ronald de Wit, MD, PhD3; David S. Mendelson, MD4; Thomas J. Smith, MD5; Mary-Ellen Taplin, MD6; James L. Wade III, MD7; Charles L. Bennett, MD, PhD8; Howard I. Scher, MD9; Paul L. Nguyen, MD6; Martin Gleave, MD10; Scott C. Morgan, MD, MSc11; Andrew Loblaw, MD, MSc12; Sean Sachdev, MD13; David L. Graham, MD14; Neha Vapiwala, MD15; Amy M. Sion, PharmD16; Virgil H. Simons, MPA17; and James Talcott, MD, SM18

بارگذاری | Download